About the role

Aplyr's Quick Take

This role is for a Learning and Development Lead at BridgeBio Pharma, focusing on creating and managing training programs for rare disease products. It's a senior position that requires project leadership and stakeholder influence, making it suitable for someone with a strong background in biotech training.

Good fit

Ideal candidates have significant experience in learning and development within the biotech sector, particularly in rare diseases. They should be adaptable, able to thrive in a fast-paced environment, and possess strong communication and project management skills.

Worth noting

The company emphasizes innovation and a non-traditional approach to biotech, which may appeal to those looking for a dynamic work culture. However, the posting lacks specific details about daily tasks and team structure.

Mavericks Wanted

When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement...read on
 
In 2015, we pioneered a “moneyball for biotech” approach, pooling projects and promising early-stage research from academia together under one financial umbrella to reduce risk and unleash innovation. This model allows science and small teams of experts to lead the way. We build bridges to groundbreaking advancements in rare disease, and develop life-changing medicines for patients with unmet needs as fast as humanly possible. 
 
Together we define white space, push boundaries, and empower people to solve problems. If you're someone who defies convention, join us and work alongside some of the most respected minds in the industry. Together, we'll ask "why not?" and help reengineer the future of biopharma. At BridgeBio, we value curiosity and experimentation—including the ethical & thoughtful use of AI to improve clarity, speed, and quality of work.

Who You Are

BBIO Training Managers are impactful, experienced individuals with a track record of success in rare disease Learning & Development within biotech:

proven ability to attain deep clinical expertise in assigned disease states/products
effectively lead complex projects, influence stakeholders and network across the Brand
communicate in a fast moving and dynamic environment

Responsibilities: Senior Manager / Associate Director, Training

Report to the Senior Director of Training and Learning Excellence, leading the design, development, implementation, and evaluation of comprehensive training curricula supporting rare Commercial launches across the BridgeBio family of companies
Build deep product, market and disease state expertise to lead end-to-end training strategy for rare therapeutic product launches and ongoing sustainment initiatives, grounded in adult learning and best practices
Source, manage, and oversee external vendors to support the development and delivery of high-quality, scalable training curricula and programs
Develop and implement impactful training initiatives that enhance clinical and marketplace knowledge and translate learning into measurable, actionable field behaviors across sales, HQ and market Access teams. Manage training content through the MLR process
Ensure all training initiatives remain compliant with regulatory requirements through close partnership with Medical, Regulatory, Legal, and Compliance stakeholders

Education, Experience & Skills Requirements

BA/BS required, advanced degree preferred
7+ years of experience in Commercial functions within the biotech/pharma industry, field sales and/or market access experience
3 years of experience in field team training
Strong clinical acumen and ability to grasp complex scientific topics and multiple brands, simultaneously in a fast-paced environment
Exhibit passion and empathy to build meaningful experiences for trainees by understanding their needs and learning styles
Excellent leadership, communication skills and self-awareness
Proven track record of effectively collaborating with and supporting a Leadership team
Commitment to comply with all laws, regulations and relevant policies that govern the conduct of BridgeBio activities

Skills & Tags

go aws ai ios data product design sales

Aplyr's read

BridgeBio Pharma is a dynamic biotechnology firm dedicated to tackling genetic diseases and cancers, attracting professionals passionate about impactful medical advancements.
Synthesized from recent postings & public sources

What's promising

•BridgeBio focuses on innovative treatments for genetic diseases, offering significant potential for groundbreaking medical advancements.
•The company has a robust pipeline with multiple late-stage clinical trials, indicating strong future growth prospects.
•BridgeBio's strategic partnerships enhance its research capabilities and expand its therapeutic reach.

What to watch

•The company faces high financial risk due to significant R&D expenditures without guaranteed success.
•BridgeBio operates in a highly competitive market with numerous established players.
•Regulatory hurdles for drug approvals can delay product launches and impact revenue.

Why BridgeBio Pharma

•BridgeBio's focus on genetic diseases and cancers sets it apart in the biotechnology sector.
•The company's decentralized model allows for nimble and efficient project management.
•BridgeBio's commitment to rare diseases addresses unmet medical needs, differentiating its mission.

Aplyr’s read is generated by AI from public sources. Was it useful?